ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,094Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 1942

$889K Total Retail Price of All Prescriptions

Rank: 7 out of 1942

464 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 464 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 464 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,654 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 404 248 1 1
HYDROCODONE-ACETAMINOPHEN 393 150 S3 2 12
LISINOPRIL 379 241 3 2
HYDROCHLOROTHIAZIDE 326 256 4 8
AMLODIPINE BESYLATE 302 178 5 6
METOPROLOL TARTRATE 258 167 6 9
OMEPRAZOLE 244 92 7 4
LEVOTHYROXINE SODIUM 242 167 8 3
METFORMIN HCL 229 133 9 10
GABAPENTIN 218 126 10 16
FUROSEMIDE 188 122 11 5
SERTRALINE HCL 184 123 12 20
OXYCODONE HCL 180 41 S2 13 52
METOPROLOL SUCCINATE 175 123 14 13
QUETIAPINE FUMARATE 171 101 15 61
OXYCODONE-ACETAMINOPHEN 162 34 S2 16 56
ZOLPIDEM TARTRATE 157 100 17 25
OXYCONTIN 146 19 S2 18 84
WARFARIN SODIUM 144 123 19 11
ATORVASTATIN CALCIUM 142 115 20 14
ATENOLOL 133 99 21 7
SPIRIVA 124 65 22 57
PANTOPRAZOLE SODIUM 110 64 23 48
TRAZODONE HCL 105 74 24 24
ABILIFY 104 26 25 155
POTASSIUM CHLORIDE 101 68 26 17
CYCLOBENZAPRINE HCL 97 21 R 27 73
LANSOPRAZOLE 93 91 28 125
MORPHINE SULFATE ER 90 36 S2 29 88
PROAIR HFA 80 32 30 41
FENTANYL 78 44 S2 31 47
VENLAFAXINE HCL ER 75 33 32 70
CYMBALTA 74 52 33 62
GLIMEPIRIDE 73 53 34 53
ALLOPURINOL 72 65 35 26
TRAMADOL HCL 69 58 36 19
SEROQUEL 67 40 37 146
TAMSULOSIN HCL 66 58 38 29
ALENDRONATE SODIUM 65 53 39 21
FLUTICASONE PROPIONATE 64 26 40 37
CITALOPRAM HBR 63 23 41 15
DONEPEZIL HCL 63 63 41 30
LYRICA 63 30 41 144
LOSARTAN POTASSIUM 62 54 44 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 24 44 22
MELOXICAM 61 45 46 81
DIVALPROEX SODIUM ER 60 0 47 167
CRESTOR 59 40 48 34
IBUPROFEN 59 22 48 78
LANTUS SOLOSTAR 59 42 48 54
CLOPIDOGREL 57 46 51 55
JANUVIA 56 40 52 85
AMITRIPTYLINE HCL 56 23 R 52 65
MIRTAZAPINE 56 44 52 38
TRIAMTERENE-HCTZ 55 50 55 36
QUINAPRIL HCL 53 42 56 171
ACTOS 52 33 57 135
ACETAMINOPHEN-CODEINE 50 44 S3 58 90
DIOVAN HCT 50 47 58 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.